UD-059Na

N/A

Report date: 2024/10/30 10:29:12
NME

Base Information

Drug NameUD-059Na
Drug Alias NameUD-059Na
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUbe Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUbe Industries Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A